Medical Management of Pediatric Malignant Bowel Obstruction in a Patient with Burkitt's Lymphoma and Ataxia Telangiectasia Using Continuous Ambulatory Drug Delivery System

Arunangshu Ghoshal, Naveen Salins, Anuja Damani, Jayita Deodhar, M. A. Muckaden

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Malignant bowel obstruction (MBO) is commonly seen in patients with advanced abdominal cancers. The incidence of pediatric MBO in a patient with Burkitt's lymphoma and ataxia telangiectasia is rare, with no published case reports till now. Conservative management of inoperable MBO results in relief of symptoms and improves quality of life. An 11-year-old boy with Burkitt's lymphoma and ataxia telangiectasia was referred to pediatric palliative care with MBO. The objective of this report is to demonstrate conservative management of pediatric MBO using continuous ambulatory drug delivery system. The patient was initiated on continuous ambulatory drug delivery (CADD) system for symptom relief. MBO was reversed with conservative management and the child was discharged on self-collapsible portable elastomeric continuous infusion pump under the supervision of a local family physician. The child remained comfortable at home for 4 weeks until his death. His parents were satisfied with the child's symptom control, quality of life, and were able to care for the child at home. In a resource-limited setting, managing patients at home using elastomeric continuous infusion pumps instead of expensive automated CADD is a practical pharmacoeconomic approach.

Original languageEnglish
Pages (from-to)44-48
Number of pages5
JournalJournal of Pain and Palliative Care Pharmacotherapy
Volume30
Issue number1
DOIs
Publication statusPublished - 02-01-2016

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Medical Management of Pediatric Malignant Bowel Obstruction in a Patient with Burkitt's Lymphoma and Ataxia Telangiectasia Using Continuous Ambulatory Drug Delivery System'. Together they form a unique fingerprint.

  • Cite this